Purple Biotech Ltd.
PPBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $12 |
| - Cash | $10 | $5 | $6 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$9 | -$5 | -$6 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -58 | -80 | -34 | -0.2 |
| % Growth | 27.5% | -135.3% | -16,900% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | -$2 |
| Capital Expenditures | $1 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | -$2 | -$2 | -$2 |